Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
äŒæ¥ã³ãŒãHNGE
äŒç€ŸåHinge Health Inc
äžå Žæ¥May 22, 2025
æé«çµå¶è²¬ä»»è
ãCEOãMr. Daniel (Dan) Perez
åŸæ¥å¡æ°1514
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«May 22
æ¬ç€Ÿæåšå°455 Market Street
éœåžSAN FRANCISCO
蚌åžååŒæNYSE Consolidated
åœUnited States of America
éµäŸ¿çªå·94105
é»è©±çªå·14156898429
ãŠã§ããµã€ãhttps://en-gb.hingehealth.com/
äŒæ¥ã³ãŒãHNGE
äžå Žæ¥May 22, 2025
æé«çµå¶è²¬ä»»è
ãCEOãMr. Daniel (Dan) Perez
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã